Literature DB >> 33408655

Cannabis and COVID-19: Reasons for Concern.

Margriet W van Laar1, Pieter E Oomen1, Charlotte J A van Miltenburg1, Eefje Vercoulen1, Tom P Freeman2, Wayne D Hall3.   

Abstract

The lockdown measures implemented to curb the spread of SARS-CoV-2 may affect (illicit) drug consumption patterns. This rapid response study investigated changes in cannabis use in a non-probability sample of cannabis users in the Netherlands during the early lockdown period. We fielded an online cross-sectional survey 4-6 weeks after implementation of lockdown measures in the Netherlands on March 15, 2020. We measured self-reported \motives for changes in use, and assessed cannabis use frequency (use days), number of joints per typical use day, and route of administration in the periods before and after lockdown implementation. 1,563 cannabis users were recruited. Mean age was 32.7 ± 12.0 years; 66.3% were male and 67.9% used cannabis (almost) daily. In total, 41.3% of all respondents indicated that they had increased their cannabis use since the lockdown measures, 49.4% used as often as before, 6.6% used less often, and 2.8% stopped (temporarily). One-third of those who were not daily users before the lockdown became (almost) daily users. Before the lockdown, most respondents (91.4%) used cannabis in a joint mixed with tobacco and 87.6% still did so. Among users of joints, 39.4% reported an increase in the average number consumed per use day; 54.2% stayed the same and 6.4% used fewer joints. This rapid response study found evidence that during the lockdown more users increased rather than decreased cannabis consumption according to both frequency and quantity. These data highlight the need to invest more resources in supporting cessation, harm reduction, and monitoring longer term trends in cannabis use.
Copyright © 2020 van Laar, Oomen, van Miltenburg, Vercoulen, Freeman and Hall.

Entities:  

Keywords:  COVID-19; cannabis; corona; risks; route of administration

Year:  2020        PMID: 33408655      PMCID: PMC7779403          DOI: 10.3389/fpsyt.2020.601653

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  21 in total

1.  Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic.

Authors:  Ryan D Assaf; Pamina M Gorbach; Ziva D Cooper
Journal:  Am J Drug Alcohol Abuse       Date:  2022-02-07       Impact factor: 3.912

2.  Cross-Sectional Retrospective Assessments versus Longitudinal Prospective Assessments of Substance Use Change among Young Adults during COVID-19: Magnitude and Correlates of Discordant Findings.

Authors:  Katelyn F Romm; Brooke Patterson; Hannah Arem; Olga Acosta Price; Yan Wang; Carla J Berg
Journal:  Subst Use Misuse       Date:  2021-12-10       Impact factor: 2.362

3.  Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany.

Authors:  Norbert Scherbaum; Udo Bonnet; Henning Hafermann; Fabrizio Schifano; Stefan Bender; Torsten Grigoleit; Jens Kuhn; Peter Nyhuis; Ulrich W Preuss; Gerhard Reymann; Udo Schneider; Jo Shibata; Michael Specka
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

Review 4.  The Immunopathology of COVID-19 and the Cannabis Paradigm.

Authors:  Nicole Paland; Antonina Pechkovsky; Miran Aswad; Haya Hamza; Tania Popov; Eduardo Shahar; Igal Louria-Hayon
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

5.  Changes in Substance Use Among People Seeking Alcohol and Other Drug Treatment During the COVID-19 Pandemic: Evaluating Mental Health Outcomes and Resilience.

Authors:  Molly Carlyle; Janni Leung; Zoe C Walter; Jennifer Juckel; Caroline Salom; Catherine A Quinn; Lily Davidson; Rhiannon Ellem; Grace Newland; Leanne Hides
Journal:  Subst Abuse       Date:  2021-12-06

Review 6.  Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression.

Authors:  Ines Gallego-Landin; Alba García-Baos; Adriana Castro-Zavala; Olga Valverde
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

7.  Trends in cannabis use among U.S. adults amid the COVID-19 pandemic.

Authors:  Savannah G Brenneke; Courtney D Nordeck; Kira E Riehm; Ian Schmid; Kayla N Tormohlen; Emily J Smail; Renee M Johnson; Luther G Kalb; Elizabeth A Stuart; Johannes Thrul
Journal:  Int J Drug Policy       Date:  2021-10-29

8.  COVID-19's Impact on Substance Use and Well-Being of Younger Adult Cannabis Users in California: A Mixed Methods Inquiry.

Authors:  Ekaterina V Fedorova; Carolyn F Wong; Bridgid M Conn; Janna Ataiants; Ellen Iverson; Stephen E Lankenau
Journal:  J Drug Issues       Date:  2022-04

9.  Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma.

Authors:  Darla E Kendzor; Sarah J Ehlke; Laili Kharazi Boozary; Michael A Smith; Amy M Cohn
Journal:  Prev Med Rep       Date:  2022-03-22

10.  Israeli news media coverage of COVID-19 and use of cannabis and tobacco: A case study of inconsistent risk communication.

Authors:  Sharon R Sznitman; Nehama Lewis
Journal:  Int J Drug Policy       Date:  2022-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.